Cargando…

Prospective observational study for perioperative volume replacement with 6% HES 130/0,42, 4% gelatin and 6% HES 200/0,5 in cardiac surgery

BACKGROUND: The constantly growing amount of different kinds of colloid fluids necessitates comparative investigations with regards to the safety and effectivity in clinical use of these preparations. Hence we compared three colloid fluids in an observational study. The objective was the exploration...

Descripción completa

Detalles Bibliográficos
Autores principales:	Winterhalter, M, Malinski, P, Danzeisen, O, Sixt, S, Monaca, E, Jüttner, T, Peiper, M, Kienbaum, P, Koester, A, Rahe-Meyer, N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351905/ https://www.ncbi.nlm.nih.gov/pubmed/20952347 http://dx.doi.org/10.1186/2047-783X-15-9-383

Ejemplares similares

Comparison of 6% HES 130/0.4 in a balanced electrolyte solution versus 6% HES 130/0.4 in saline solution in cardiac surgery
por: Base, E, et al.
Publicado: (2006)

Efficacy and safety of 10% HES 130/0.4 versus 10% HES 200/0.5 for plasma volume expansion in cardiac surgery patients
por: Ertmer, C, et al.
Publicado: (2011)

HES 130/0.4, a new HES specification: tissue storage after multiple infusions in rats
por: Bepperling, F, et al.
Publicado: (1999)

Volume substitution therapy with HES 130/0.4 (Voluven(®)) versus HES 450/0.7 (hetastarch) during major orthopedic surgery
por: Gandhi, S, et al.
Publicado: (2005)

HES 130/0.4, a new HES specification: pharmacokinetics after multiple infusions of 10% solutions in healthy volunteers
por: Bepperling, F, et al.
Publicado: (1999)

Prospective study comparing skin impedance with EEG parameters during the induction of anaesthesia with fentanyl and etomidate
por: Winterhalter, M, et al.
Publicado: (2010)

Concerns about renal safety of HES 130
por: Wiedermann, Christian J, et al.
Publicado: (2013)

HES 130/0.4 impairs haemostasis and stimulates pro-inflammatory blood platelet function
por: Sossdorf, Maik, et al.
Publicado: (2009)

In vivo effect of hydroxyethyl starch solution (HES 130/0.4) on different fibrinogen assays
por: Schött, U, et al.
Publicado: (2014)

Balanced Hydroxyethylstarch (HES 130/0.4) Impairs Kidney Function In-Vivo without Inflammation
por: Schick, Martin Alexander, et al.
Publicado: (2015)

Sumoylation of Hes6 Regulates Protein Degradation and Hes1-Mediated Transcription
por: Lee, Jiwon, et al.
Publicado: (2015)

Large-dose hydroxyethyl starch (HES) 130/0.4 in elective coronary artery bypass surgery
por: Kasper, SM, et al.
Publicado: (2002)

Evaluation of effectiveness and safety of hydroxyethyl starch (HES 130 kDa/0.4) in burn resuscitation
por: Mokline, A, et al.
Publicado: (2012)

Does volume substitution with HES 130/0.4 affect renal safety in abdominal aortic surgery?
por: Godet, G, et al.
Publicado: (2006)

HES6-1 and HES6-2 Function through Different Mechanisms during Neuronal Differentiation
por: Vilas-Boas, Filipe, et al.
Publicado: (2010)

Hydroxyethyl starch 130/0.42/6:1 for perioperative plasma volume replacement is safe and effective in children
por: Suempelmann, R, et al.
Publicado: (2008)

Effect of intraoperative HES 6% 130/0.4 on the need for blood transfusion after major oncologic surgery: a propensity-matched analysis
por: Zampieri, Fernando Godinho, et al.
Publicado: (2013)

6% Hydroxyethyl starch (HES 130/0.4) diminishes glycocalyx degradation and decreases vascular permeability during systemic and pulmonary inflammation in mice
por: Margraf, Andreas, et al.
Publicado: (2018)

Assessment of Hydroxyethyl Starch (6% HES 130/0.4) Kidney Storage in Critically Ill Dogs: A Post-mortem Prospective Study
por: Adamik, Katja-Nicole, et al.
Publicado: (2022)

Hydroxyethyl starch HES 130/0.4 in paediatric surgery: results of an explorative, controlled, multicentre safety study
por: Lochbühler, H, et al.
Publicado: (2003)

Hydroxyethyl starch 200/0.5 induces more renal macrophage infiltration than hydroxyethyl starch 130/0.42 in an isolated renal perfusion model
por: Hüter, L, et al.
Publicado: (2008)

In vitro effects of 6 % hydroxyethyl starch 130/0.42 solution on feline whole blood coagulation measured by rotational thromboelastometry
por: Albrecht, Nathalie A., et al.
Publicado: (2016)

The Evaluation of Hydroxyethyl Starch (6% HES 130/0.4) Solution’s Potential Preventive Effects on Coagulation Status in Women with Gynecologic Malignancies Using Rotation Thromboelastography
por: Akay, Meltem Olga, et al.
Publicado: (2014)

Hes-6, an inhibitor of Hes-1, is regulated by 17β-estradiol and promotes breast cancer cell proliferation
por: Hartman, Johan, et al.
Publicado: (2009)

He’s Come!!
por: Stewart, A. T.
Publicado: (1869)

Adverse effects of hydroxyethyl starch (HES 130/0.4) on intestinal barrier integrity and metabolic function are abrogated by supplementation with Albumin
por: Wong, Yuk Lung, et al.
Publicado: (2016)

The effect of HES130/0.4 sodium chloride solution on kidney function following early fluid resuscitation in shock patients
por: Jiang, Haiyan, et al.
Publicado: (2021)

Circadian regulation of low density lipoprotein receptor promoter activity by CLOCK/BMAL1, Hes1 and Hes6
por: Lee, Yeon-Ju, et al.
Publicado: (2012)

Recent advances in understanding the role of HES6 in cancers
por: Krossa, Imène, et al.
Publicado: (2022)

The impact of 30 ml/kg hydroxyethyl starch 130/0.4 vs hydroxyethyl starch 130/0.42 on coagulation in patients undergoing abdominal surgery
por: Staikou, Chryssoula, et al.
Publicado: (2012)

(S)-2-Methylpiperazinediium dichloride 0.42-hydrate
por: Harrison, William T. A.
Publicado: (2008)

Low-quality Trials as a Source of Heterogeneity in the Association of Hydroxyethyl Starch 130/0.4 or 0.42 with Excess Mortality in Sepsis
por: Wiedermann, Christian J
Publicado: (2016)

Hes6 Is Required for the Neurogenic Activity of Neurogenin and NeuroD
por: Murai, Kasumi, et al.
Publicado: (2011)

PB2204: THE ROLE OF HES6 IN NORMAL HUMAN HEMATOPOIESIS
por: De Vos, T., et al.
Publicado: (2022)

Renal Safety of Hydroxyethyl starch 130/0.42 After Cardiac Surgery: A Retrospective Cohort Analysis
por: Morath, Benedict, et al.
Publicado: (2021)

Comparison of hydroxyethylstarch (HES 130/0.4) and 5% human albumin for volume substitution in pediatric neurosurgery: A retrospective, single center study
por: Schick, Martin A., et al.
Publicado: (2021)

Effects of colloid-based (hydroxyethylstarch 6% 130/0.42, gelafundin 4%) and crystalloid-based volume regimes in cardiac surgery: a retrospective analysis
por: Datzmann, Thomas, et al.
Publicado: (2022)

Changes in the degree of substitution of HES in vivo and their influence on methods for determining HES concentrations in plasma
por: Lukasewitz, Peter, et al.
Publicado: (2023)

Markers of endothelial dysfunction in patients with severe sepsis resuscitated with hydroxyethyl starch 130/0.42 vs. ringer's acetate
por: Müller, RB, et al.
Publicado: (2015)

HES6 promotes prostate cancer aggressiveness independently of Notch signalling
por: Carvalho, Filipe L F, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1fu3p2l46ao7cgr9g4vbsa5ior